HUTCHMED (China) Limited (HCM)
NASDAQ: HCM · IEX Real-Time Price · USD
17.22
-0.34 (-1.94%)
Jul 2, 2024, 4:30 PM EDT - Market closed
HUTCHMED (China) Employees
HUTCHMED (China) had 1,988 employees as of December 31, 2023. The number of employees decreased by 37 or -1.83% compared to the previous year.
Employees
1,988
Change (1Y)
-37
Growth (1Y)
-1.83%
Revenue / Employee
$421,529
Profits / Employee
$50,694
Market Cap
3.00B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1,988 | -37 | -1.83% |
Dec 31, 2022 | 2,025 | 266 | 15.12% |
Dec 31, 2021 | 1,759 | 479 | 37.42% |
Dec 31, 2020 | 1,280 | 427 | 50.06% |
Dec 31, 2019 | 853 | 139 | 19.47% |
Dec 31, 2018 | 714 | 124 | 21.02% |
Dec 31, 2017 | 590 | 27 | 4.80% |
Dec 31, 2016 | 563 | 112 | 24.83% |
Dec 31, 2015 | 451 | 102 | 29.23% |
Dec 31, 2014 | 349 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Amedisys | 19,000 |
Surgery Partners | 13,500 |
LivaNova | 2,900 |
Olink Holding AB (publ) | 707 |
GoodRx Holdings | 694 |
PROCEPT BioRobotics | 626 |
Amicus Therapeutics | 517 |
Xenon Pharmaceuticals | 259 |
HCM News
- 6 days ago - HUTCHMED to Announce 2024 Half-Year Financial Results - GlobeNewsWire
- 8 days ago - Save the Date: HUTCHMED to Present R&D Updates on July 9, 2024 - GlobeNewsWire
- 11 days ago - HUTCHMED Announces European Commission Approval for FRUZAQLA® (fruquintinib) Received by Takeda - GlobeNewsWire
- 16 days ago - HUTCHMED Highlights Publication of Phase III ESLIM-01 Results in The Lancet Haematology - GlobeNewsWire
- 26 days ago - HUTCHMED Initiates Phase I Trial of Menin Inhibitor HMPL-506 in Patients with Hematological Malignancies in China - GlobeNewsWire
- 4 weeks ago - HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature Medicine - GlobeNewsWire
- 5 weeks ago - HUTCHMED Highlights Presentations at the 2024 ASCO Annual Meeting - GlobeNewsWire
- 6 weeks ago - HUTCHMED announces retirement of Chairman, appointment of new Chairman and change of members of board committees - GlobeNewsWire